Market Overview

US Stock Futures Up; Jobless Claims Data In Focus

US Stock Futures Up; Jobless Claims Data In Focus
Related EROC
Another Deal Unveiled By Vanguard Natural Resources
Morning Market Gainers
Related HITK
Hi-Tech Pharmacal Receives FDA Final Approval for Bromfenac Ophthalmic Solution, 0.09%
Hi-Tech Pharmacal Announces $25M Settlement Regarding Texas Pricing Investigation

Pre-open movers

US stock futures gained in early pre-market trade, ahead of jobless claims data. Data on weekly jobless claims will be released at 8:30 a.m. ET. Futures for the Dow Jones Industrial Average surged 45 points to 16,348.00, while the Standard & Poor's 500 index futures gained 2.70 points to 1,831.80. Futures for the Nasdaq 100 index rose 5.50 points to 3,575.25.

A Peek Into Global Markets

Asian markets ended mostly higher today. Japan's Nikkei Stock Average rose 1.03%, China's Shanghai Composite tumbled 1.58% and India's BSE Sensex rose 0.2%.

Broker Recommendation

Analysts at Raymond James upgraded Eagle Rock Energy Partners LP (NASDAQ: EROC) from “underperform” to “market perform.”

Eagle Rock Energy's shares closed at $6.35 on Tuesday.

Breaking news

  • Hi-Tech Pharmacal (NASDAQ: HITK) today announced that the Texas Attorney General has agreed to close its investigation of Hi-Tech's pricing of products that were purchased with Texas Medicaid dollars. To read the full news, click here.
  • Capital Senior Living (NYSE: CSU) today announced that it has completed the acquisition of four senior living communities in two transactions for a combined purchase price of approximately $64.9 million. To read the full news, click here.
  • Goodrich Petroleum (NYSE: GDP) today announced that its Huff 18-7H-1 (97% WI) well in Amite County, Mississippi was successfully fracture stimulated with 17 stages and had commenced flowback at expected fluid rates when the well became plugged up with frac-related debris at a frac plug approximately 500 feet into the lateral, which will need to be cleaned out prior to resuming flowback. To read the full news, click here.
  • DS Healthcare Group (NASDAQ: DSKX) announced that it entered and consummated a securities purchase agreement with an accredited investor for the sale of 1,512,500 shares of the Company's common stock, with gross proceeds of $2,420,0000. To read the full news, click here.

Posted-In: Raymond James US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (CSU + DSKX)

View Comments and Join the Discussion!